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Clinical and experimental studies have highlighted the significance of inflammation in coordinating wound repair and
regeneration. However, it remains challenging to control the inflammatory response and tolerance at systemic levels without
causing toxicity to injured tissues. Mesenchymal stem cells (MSCs) possess potent immunomodulatory properties and facilitate
tissue repair by releasing exosomes, which generate a suitable microenvironment for inflammatory resolution. Exosomes contain
several effective bioactive molecules and act as a cell-cell communication vehicle to influence cellular activities in recipient cells.
During this process, the horizontal transfer of exosomal microRNAs (miRNAs) to acceptor cells, where they regulate target
gene expression, is of particular interest for understanding the basic biology of inflammation ablation, tissue homeostasis, and
development of therapeutic approaches. In this review, we describe a signature of three specific miRNAs (miR-21, miR-146a,
and miR-181) present in human umbilical cord MSC-derived exosomes (MSC-EXO) identified microarray chip analysis and
focus on the inflammatory regulatory functions of these immune-related miRNAs. We also discuss the potential mechanisms
contributing to the resolution of wound inflammation and tissue healing.
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INTRODUCTION
Inflammation is an evolutionarily biophysical self-defense re-
sponse of the body to harmful stimuli and aims to maintain a
homeostatic state (Kizil et al., 2015). Immune cells, mainly
resident macrophages, dendritic cells, and neutrophils, are ac-
tivated during inflammation and recruited to the impaired site
to initiate the healing process by eradicating pathogens and
damaged cells. Although an acute and well-regulated inflam-
matory response is typically crucial for returning cells and
organisms to homeostasis, chronic and inappropriate inflam-
mation is hazardous to tissues and predisposes patients to the
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onset or progression of delayed wound healing (Sugimoto et
al., 2016; Landén et al., 2016). Therefore, the regulation of
inflammation is a potential therapeutic target for intervention
to reduce the risk of disease and disability.
Recently, stem cell-based technologies using mesenchymal
stem cells (MSCs) have been proposed for the treatment of
inflammation-related diseases (Liu et al., 2016; Gao et al.,
2016; Shen et al., 2015). MSCs are a population of self-re-
newing undifferentiated adult cells that can be obtained from
different tissues (bone marrow, umbilical cord, adipose, etc.)
and are typically defined as plastic-adherent, fibroblast-like
cells with the potential to differentiate along a distinct vari-
ety of cell lineages. They can home to the injured sites, in-
teract with several cells of the immune system, and modulate
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the local microenvironment through their unique immunolog-
ical properties. Bury et al. found that MSC grafts markedly
reduced the presence of pro-inflammatory macrophages and
neutrophils, attenuated the innate inflammatory response, and
facilitated bladder tissue regeneration (Bury et al., 2015). In
addition, administeredMSCsmay inhibit dendritic cell differ-
entiation and maturation, reduce lymphocyte activities, and
decrease the cytotoxic activity of natural killer cells in acute
kidney injury (De Miguel et al., 2012).
Increasing evidence has suggested that MSCs secrete
exosomes as vital extracellular communicators to modulate
the proliferation, activation, and effector function of targeted
cells and have therapeutic effects on wound inflammation
(Fontaine et al., 2016; Ophelders et al., 2016; Nakano et al.,
2016). Exosomes, which were first defined by Trams et al.,
are small biological lipid membrane vesicles with diameters
for 40–100 nm (Trams et al., 1981). Researchers determined
the exosome biogenesis process in different cell types and
successfully isolated these membranous bodies from diverse
sources, ranging from bodily fluids to the supernatants of cul-
tured cells. Under physiological and pathological conditions,
these vesicles are formed by inward budding of late endo-
somes and then released into the extracellular environment
upon fusion with the plasma membrane (Basso and Bonetto,
2016). They can shuttle biologically active molecules, such
as intact and functional microRNAs (miRNAs), messenger
RNAs (mRNAs), and proteins, to targeted recipient cells
and reprogram cell behaviors (Zhou et al., 2016; Fang et al.,
2016).
miRNAs are highly conserved, small (19–24 nt), non-cod-
ing RNA molecules that regulate gene expression at the
post-transcriptional level by promoting the degradation or
blocking of mRNA translation. It has been reported that
several miRNAs play crucial roles in regulating different
inflammatory responses in many tissues and affect the phe-
notype and development of immune cells. Dysregulation
of miR-21 or miR-181 induces a chronic inflammatory
state; this miRNA is key in controlling the balance be-
tween initial pro-inflammatory and later immuno-regulatory,
anti-inflammatory responses (Garo and Murugaiyan, 2016;
Sun et al., 2014). As master molecular switches, miRNAs
exchange bio-information between neighboring cells and
are important in exosome-mediated microenvironmental
changes (Cavalieri et al., 2016; Navakanitworakul et al.,
2016). Montecalvo et al. showed that miRNAs in exosomes
are remarkably stable, likely because of their unique struc-
ture that protects them against harsh degrading conditions,
such as low acidic pH and RNase-mediated degradation
(Montecalvo et al., 2012). miRNAs transferred through
exosomes, such as miR-146a and miR-155, are expressed
in a tissue- and cell type-specific manner and can alter the
host cell to evade the host’s innate immune response and
influence their survival and activated or differentiated status
(Alexander et al., 2015). In addition, the miRNA component
of exosomes is heterogeneous and depends on the cells of
origin. Various microenvironmental factors, including cal-
cium concentration and growth factors, can also influence the
transport of information by exosomes and their regulatory
properties (Taverna et al., 2016).
MSC-derived exosomes (MSC-EXO) have been proposed
as an ideal therapeutic strategy for wound inflammation.
When exposed to an extremely harsh inflammatory mi-
croenvironment within injured sites, engrafted stem cells
exhibit low survival rates, limiting their sustained reparative
capacity. Exosomes resist external degradation and provide
target cells with effective genetic information, and thus
MSC-EXO may be non-invasive and dynamic candidates as
gene therapy vectors to communicate important regulatory
signals between cells and mediate protective signals against
stress in other cells during wound inflammation. miRNA
“marker signatures”, which are carried and secreted by
MSC-EXO, may participate in the resolution of chronic
inflammation and enhance the curative effects of MSCs. A
better understanding of the miRNA expression profiles and
putative specific miRNA functions within MSC-EXO will
facilitate further development of MSC-mediated exosome
therapy aimed at the modification of wound inflammation.
HOW MSCS FUNCTION IN WOUND
INFLAMMATION
Inflammation is not only an essential step of wound heal-
ing but also has large impacts on the final wound outcome.
If unchecked and persistent, it can lead to delayed wounds
that are characteristic of fibrosis, excessive scar formation,
or inhibiting reepithelialization. Numerous basic and clini-
cal data over the last decade indicate that the anti-inflamma-
tory and immunomodulative properties of MSCs are partic-
ularly beneficial for poor wound treatment, as they advance
the wound’s capacity to progress beyond the inflammatory
stage and not transit to an impaired wound state (Gao et al.,
2016; van den Akker et al., 2013). After the immunomodu-
latory capacities are activated by the inflammatory microen-
vironment of the wound sites, MSCs secrete different bioac-
tive components, exert pleiotropic effects on immune cells at
injured sites, and play a protective role in remedying tissue
inflammation and improving healing. In a mouse model of
autoimmune encephalomyelitis, MSCs effectively inhibited
Th17 cell polarization and ameliorated the development of
autoimmune responses by secreting large amounts of soluble
TNF receptor to antagonize TNF-α function (Ke et al., 2016).
TNF-α is considered as a major proinflammatory medium in
the promotion of Th17 cell differentiation and the pathophys-
iology of autoimmune encephalomyelitis. Additionally, Xu
et al. found that accelerated diabetic wound healing by MSC
treatment was associated with significantly up-regulated ex-
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pression of miR-146a and suppression of proinflammatory
target genes expression (Xu et al., 2012). Based on these stud-
ies, MSC may reprogram a well-orchestrated and proregen-
erative microenvironment for inflammation adjustment then
induce functional restoration of injured tissues, which may
be primarily related to the paracrine mechanism triggered by
MSCs. As active ingredients of trophic secretion by MSCs,
exosomes are important regulators of cell-to-cell communi-
cation for inflammatory signaling and wound repair by shut-
tling functional materials such as protein and miRNAs. Stud-
ies have shown that MSC-EXO significantly depressed lym-
phocyte proliferation, restrained the inflammatory response,
and played a cardioprotective role. A decrease in the concen-
tration of exosomes, results in the slower recovery of dam-
aged hearts (Teng et al., 2015). Thus, further investigations
are necessary to explain the transporter roles of MSC-EXO
in wound healing and analyze the composition of exosomes
to reveal their detailed mechanisms in chronic inflammation.
MIRNA EXPRESSION PATTERNS RELEASED
BY MSC-EXO
Computational and indirect evidence has indicated that
miRNAs directly manage up to one-third of protein-coding
genes. They act as critical immune-modulators of diverse
processes, including the differentiation and induction of
immune cells and maintenance of cellular homeostasis and
functions (Mehta and Baltimore, 2016). For example, pre-
conditioning of MSCs triggers internal changes in cells,
possibly at the post-transcriptional and/or epigenetic levels,
which are responsible for subsequent gene reprogramming
or robust immune tolerance (Zhang et al., 2016; Dong et
al., 2015; Aktas et al., 2016). In our previous study, we
found that lipopolysaccharide (LPS) priming can augment
the paracrine protective ability and therapeutic potentiality
of MSCs; additionally, let-7b was distinctively shuttled by
LPS-pretreated MSC-derived exosomes (LPS pre-Exo), may
function in the balance of macrophage polarization to cure
chronic inflammation and enhance skin wound repair (Ti et
al., 2015). MiRNAs are induced in a time-specific manner,
and the resulting regulatory network is often very extensive
and complicated. Therefore, it is not surprising that miRNAs
are partially taken up by MSCs as cargo in exosomes to
influence coordinated changes in gene expression occurring
during the resolution of wound inflammation.
Therefore, in order to explore whether MSC-EXO exert
the immunomodulative properties through specific miRNAs,
we cultured human umbilical cord MSCs at the 4th–5th pas-
sages, harvested exosomes from the supernatants of MSCs by
gradient centrifugation, and conducted microarray analysis
to determine the miRNA expression profile of MSC-EXO
(Ti et al., 2015). Following probe screening and data normal-
ization, we found 42 significantly differentially expressed
miRNAs compared to in human fibroblast-derived exosomes
(FIB-EXO, Figure 1). Among 15 up-regulated miRNAs,
three (miR-21, miR-146a, and miR-181) displayed the most
significant and highest expression in MSC-EXO (data not
shown). Next, we performed bioinformatics prediction to de-
termine potential downstream targets of miR-21, miR-146a,
and miR-181. According to the Reactome Database, targets
of these three specific miRNAs were statistically enriched
in genes and proteins participating in cellular development
and function, innate immune response, inflammation, and
cell signaling. Particularly, the Toll-like receptor (TLR)
pathway and IL-6 pathway have been shown to be important
cellular pathways fundamentally required for activation of
the immune system and orchestration of the inflammatory
process after tissue damage.
Given the essential role of the miRNA processing machin-
ery in immune cell development and inflammatory responses,
we hypothesized that these three specific miRNAs in MSC-
EXO could modulate the expression of inflammation-related
genes, which may reduce delayed inflammation and enhance
wound healing. However, little is known about how and to
what extent these miRNAs function in the immune stimula-
tory program of MSCs, which is an important issue for po-
tential therapeutic molecule discovery to coordinate uncon-
trolled inflammation. We reviewed their biological activities
interacting with inflammatory cells and directly regulating
intracellular regulatory mechanisms or affecting the cellular
phenotype in the resolution of wound inflammation.
miR-21
miR-21 can be selectively packaged from original cells
into exosomes and acts as a rheostat to modulate immune
cell function and the inflammatory response. Pieters et
al. demonstrated that extracellular vesicles, including exo-
somes, which were isolated from commercial bovine milk,
could induce Th17 differentiation in murine splenocytes,
and miR-21 was present in the immunoregulatory cargo
carried by these extracellular vesicles (Pieters et al., 2015).
In addition, data analyses of the human MSC secretome
confirmed that miR-21 protects MSCs under serum-de-
prived conditions and can trigger key biological functions
in recipient cells (Nie et al., 2011). Efficient efferocytosis
induces potent anti-inflammatory and immunosuppressive
mechanisms that are required for the timely resolution of
inflammation. Notably, miR-21 is efferocytosis-inducible
in macrophages, subsequently promoting efferocytosis pro-
gression. In the regulatory loop, miR-21 silences PTEN and
GSK3β, dampens NFκB activation, and promotes c-Jun/AP1
activities, which control the inflammatory response and pro-
mote wound healing (Das et al., 2014). Furthermore, miR-21
is instrumental in the regulation of macrophage phenotype
and inflammation ablation for efficient stem cell-dependent
tissue repair.  In  response  to  bacterial  infections,  miR-21
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Figure 1   Analysis of miRNA expression profiling in MSC-EXO. A heatmap was generated after supervised hierarchical cluster analysis. Differential miRNA
expression is shown in red (upregulation) versus green (downregulation) intensity (MSC-EXO versus FIB-EXO, 2-fold change, P<0.05).
leads to NFκB activation in pro-inflammatory macrophages,
thus promoting both inflammation and the expression of anti-
inflammatory genes. It then depresses PTEN in anti-inflam-
matory macrophages, resulting in AKT activation to cause in-
flammation alleviation and wound healing (Perdiguero et al.,
2011). Hence, we suggest that miR-21 is a highly interest-
ing and significant player in downstream inflammatory path-
ways and post-host immune responses mediated by diverse
immune cells; the expression of miR-21 in MSC-EXO may
be involved in the modulation of the inflammatory response
during tissue repair.
miR-146a
miR-146a was previously shown to be highly expressed in
multiple types of adult stem cells. Furthermore, miR-146a
may play a role in mediating short-term memory in immune
system cells and MSCs after environmental stimulation.
When MSCs migrate to the inflammatory microenvironment
in injured tissues, they possess a “short-term memory” for
danger signals and display enhanced therapeutic immunoreg-
ulation efficacy by inducing stimulus-responsive regulatory
molecules, such as miR-146a (Liu et al., 2016). Saba et al.
suggested that in response to inflammatory cues, miR-146a
can function as a key regulator of the innate immune re-
sponse to arrest the expression of several pro-inflammatory
factors, including TNF-α, IL-6, and IFN-γ, and direct the in-
flammatory response (Saba et al., 2014). miR-146a can also
protect the functional capabilities and longevity of murine
hematopoietic stem cells against prolonged inflammation;
these cells are critical for an adequate inflammatory and
immune response in healthy individuals (Zhao et al., 2013).
In addition, miR-146a regulates not only the acute T cell re-
sponse but also chronic T cell hyper-inflammatory response
and development of T cell-associated autoimmunity. This is
achieved by repressing NFκB activity and monitoring the T
cell response to antigen stimulation during T cell activation
(Meisgen et al., 2014). Etzrodt et al. showed that miR-146a
may regulate monocyte subset population dynamics. In vivo
enhancement of miR-146 transcription in macrophages and
monocytes can attenuate monocyte/macrophage activation
and inhibit pro-inflammatory macrophage responses to sup-
press NFκB-mediated inflammation (Etzrodt et al., 2012).
Thus, MSC-shuttled exosomal miR-146a may have a diverse
and critical role in limiting an excessive inflammatory reac-
tion, and therefore represent a future therapeutic target for
exogenous modulation of wound inflammation.
miR-181
Experiments have shown that miR-181 plays an important
role in the development, differentiation, and activation of T
lymphocytes, B lymphocytes, and natural killer cells (Chen
et al., 2004; Beaulieu et al., 2013). The immune system
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mounts rapid and specific defense responses and develops
and maintains a steady microenvironment; if deregulated,
this can result in decreased regenerative capacity and various
pathological disorders, including defects in host-pathogen
interactions, autoimmune diseases, or chronic inflammation.
Thus, miR-181 may provide excellent spatio-temporal mon-
itoring of immune cells, modulate the strength and threshold
of immune signals under physiological and pathological con-
ditions, and switch outcomes on immune responses for tissue
homeostasis. When miR-181 is deficient in a specific tissue
in mice, conventional T cell and natural killer T cell devel-
opment were perturbed and PI3K signaling was impaired,
which results from the cumulative effect of increased PTEN
expression (Henao-Mejia et al., 2013). Dan et al. suggested
that miR-181 upregulation is the primary host protective
method against endotoxin shock, as it can switch the im-
mune status from hyperinflammation to endotoxin tolerance
by quickly decreasing inflammatory cytokine expression
without influencing the expression of anti-inflammatory
cytokines (Dan et al., 2014). In an experimental neuroin-
flammatory model, miR-181 was found to be necessary for
the reactive phenotype of astrocytes to inflammatory settings
by reprogramming the transcriptional profiles of general cell
differentiation and stress responses (Hutchison et al., 2013).
These results clearly illustrate that miR-181 plays a central
role in anabolic metabolism in immune cells and fine-tunes
their immunological functions to prevent overwhelming
inflammation during tissue regeneration.
UNIQUE MICRORNA EXPRESSION
IN MSC-EXO CONTRIBUTES TO THE
RESOLUTION OF WOUND INFLAMMATION
Increasing data have shown that MSC-EXO have specific bi-
ological functions for modulating the immune and inflamma-
tory response and repairing tissue damage. The manipulation
of genetic elements using selective exosomal regulation may
have fully or partially penetrant effects on pathological con-
ditions at the cellular and systemic levels. Blazquez et al.
showed that MSC-EXO have an inhibitory role in the differ-
entiation, proliferation, and activation of T cells and IFN-γ
release during the treatment of inflammation-related diseases
(Blazquez et al., 2014). These observations suggest that spe-
cific therapeutic miRNA populations in MSC-EXO reshape
the immunomodulatory strength of MSCs to mediate target
immune cell activation, phenotypic modification, and repro-
gramming of cell function. Moreover, in our study, bioinfor-
matic approaches indicated that specific miRNAs shuttled by
MSC-EXO have complex pleiotropic effects on many aspects
of inflammation. These miRNAs are predicted to target im-
mune and inflammatory response genes, including transcrip-
tion factors, co-factors, and chromatin modifiers. In addition,
critical proteins involved in regulating inflammation, such as
TLRs and IL-6, have been suggested to act as links between
MSC-EXO and inflammatory pathway activation in immune
cells. Therefore, studies of the immune signals andmechanis-
tic pathways regulated by miR-21, miR-146a, and miR-181
may enable better modulation of inflammation and advanced
methods for stem cell-mediated tissue repair.
TLR signaling pathway
TLRs are a class of membrane-bound pattern recognition
receptors that are responsible for recognizing particular
pathogen-associated molecular patterns from infectious
pathogens. The immune system mainly detects and iden-
tifies pathogenic molecules via TLRs then triggers various
transcription factors, leading to strong production of pro-in-
flammatory cytokines (Sabouri et al., 2014; Helley et al.,
2015). Inappropriate quantities or qualities of TLR ligands
or aberrant response to TLR activation have been observed in
various impaired inflammatory conditions. miRNA, which
inhibits protein expression through mRNA degradation or
translational repression, can be used to precisely regulate the
immune system and immune cell activity. Therefore, specific
miRNAs in MSC-EXOmay strictly modulate TLR-signaling
pathways to prevent excessive inflammation and achieve
a balanced microenvironment. For example, miR-146a is
a regulatory element in keratinocyte innate immunity that
suppresses the expression of a large number of inflammatory
genes under homeostatic conditions and serves as a potent
negative feedback regulator of the TLR proinflammatory
pathway. Furthermore, miR-181 directly binds to the 3′
untranslated region of IL-8, and represses its expression in
human fibroblasts. Thus, upregulation of miR-181 may be
associated with the homeostatic response to inflammatory
stimuli such as IL-8 by TLR pathway activation (Galicia et
al., 2014).
Once activated, the TLR pathway acts through different
intracellular signaling cascades and leads to activation of
NFκB and TRIF-dependent signaling, resulting in cytokine,
chemokine, and cell adhesion molecule induction. Evi-
dence is accumulating that miRNAs function as important
immunomodulators to fine-tune the TLR-induced NFκB
signaling pathways and downstream consequences. miR-21
was induced by the TLR/NFκB pathways in LPS priming
human peripheral blood mononuclear cells, in turn, repress-
ing the NFκB pathway and upregulating IL-10 production
(Sheedy et al., 2010). Feng et al. found that miR-21 inhibits
lipid-laden foam cell formation and inflammatory responses
in LPS-stimulated macrophages through the TLR4-NF-κB
pathway (Feng et al., 2014). Hence, we hypothesize that par-
ticular miRNAs in MSC-EXO create a regulatory feedback
to monitor certain TLR-activated transcription factor-depen-
dent pathways and timely decrease and/or terminate TLR
signaling by targeting the expression of critical signaling
components.
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IL-6 signaling pathway
IL-6 is a pleiotropic cytokine that regulates multiple bi-
ological processes, including acute phase responses, cell
regeneration, inflammation, and immune responses. As a
pro-inflammatory soluble factor, IL-6 produced by mono-
cytes-macrophages represents a key molecule in the induc-
tion and maintenance of delayed inflammation during RA
progression. Some evidence suggests that IL-6 compromises
tissue repair by shifting acute inflammation into a more
chronic profibrotic state induced by Th1 cells as a conse-
quence of recurrent inflammation (Fielding et al., 2014). In
all cases tested, blockade of IL-6 by specific miRNAs in
MSC-EXO may be a useful therapeutic measure for wound
inflammation. For example, in a mathematical inflammation
model, miR-146 and miR-21 significantly controlled the
coupled inflammatory reactions by fine-tuning the activation
dynamics of the key mediators of IL-6 (Xue et al., 2013).
After LPS exposure, increased miR-181 may be involved in
decreasing IL-6 expression, which may be also an important
regulatory mechanism for controlling the pro-inflammatory
immune response and induction of endotoxin tolerance
(Zhang et al., 2015).
In the classic signaling pathway, IL-6 binding to the
membrane-bound IL-6 receptor (IL-6R) is followed by ho-
modimerization of IL-6R with its signal-transducing element
gp130 and initiation of the phosphorylation of the tran-
scription factors STAT3. It has been demonstrated that the
IL-6-gp130-STAT3 signaling axis is necessary for the orches-
tration of inflammatory processes in animal models (Hirano,
2010). The identification of novel upstream modulators or
downstream targets of the IL-6/STAT3 pathway will provide
insight into the involvement of altered miRNA expression
in the progression of chronic inflammation. In RA patients,
the expression levels of miR-21 were significantly lower and
accompanied by increased STAT3 expression and activation
(Dong et al., 2014). Moreover, Iliopoulos et al. found that
miR-21 and miR-181 are rapidly and dramatically regulated
during cellular transformation. A transient inflammatory sig-
nal triggers the inflammatory feedback loop involving IL-6,
STAT3, miR-21, and miR-181 and induces an epigenetic
switch that links inflammation to cancer; the transformed
state can be interrupted by any genetic or environmental
change affecting the factors of the inflammatory feedback
loop (Iliopoulos et al., 2010). These complex mechanisms
provide a paradigm for molecular target therapy in which a
key process of disease progression involves miRNA-induced
changes in response to an inflammatory signal.
PERSPECTIVES AND FINAL REMARKS
In this review, we examined the miRNAs profiling in
MSC-EXO and explored the impacts of selected miRNAs
(miR-21, miR-146a, and miR-181) on inflammatory re-
sponses and tolerance at the molecular, cellular, and systemic
levels. miRNA expression may be turned on or off at the
transcriptional level upon ligand stimulation and can have
either positive or negative effects on the expression of sig-
naling components that impact the development or function
of different target cells. In some inflammatory disorders,
studies have suggested that prominent up-regulation of
miRNAs, such as miR21, is specifically involved in modu-
lating TLR associated NFκB signaling networks activated
by the pathological microenvironment (Kalla et al., 2015).
Conceivably, miR146a is differentially expressed in various
autoimmune diseases including rheumatoid arthritis and
multiple sclerosis and its regulation may influence the de-
velopment or prevention of autoimmunity (Dai and Ahmed,
2011). As exosomes naturally transfer RNA molecules
between cells, this property may be useful in gene therapy,
in which a vector is used to deliver therapeutic nucleic acids
to the patient’s target cells. Researchers have reported that
exosomes can deliver synthetic miR-143 and are a poten-
tially efficient and functional delivery system (Shimbo et al.,
2014). These examples suggest that MSC-EXO may balance
the dysregulated inflammatory condition without causing
significant toxicity through specific miRNAs and can be used
as efficient vehicles in RNA-based therapeutic strategies.
Such efforts will ultimately reveal the immunoregulation
function of miRNA and evaluation of whether their release
via MSC-EXO is involved in the resolution of chronic in-
flammation and orchestrating wound healing.
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